{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:19:51Z","timestamp":1791937191986,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd011091","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,23]],"date-time":"2015-08-23T00:00:00Z","timestamp":1440288000000}}],"reference-count":66,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011091.pub2","type":"journal-article","created":{"date-parts":[[2015,8,23]],"date-time":"2015-08-23T22:44:46Z","timestamp":1440369886000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Venlafaxine for neuropathic pain in adults"],"prefix":"10.1002","volume":"2017","author":[{"given":"Helen C","family":"Gallagher","sequence":"first","affiliation":[{"name":"University College Dublin; School of Medicine and Medical Science, Conway Institute; Belfield Dublin 4 Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Princess of Wales Hospital; Cathedral Medical Centre; Lynn Road Ely Cambridgeshire UK CB6 1DN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Butler","sequence":"additional","affiliation":[{"name":"The University of British Columbia; Midwifery Program, Department of Family Practice; B54 - 2194 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal J","family":"Buggy","sequence":"additional","affiliation":[{"name":"University College Dublin; School of Medicine and Medical Science, Conway Institute; Belfield Dublin 4 Ireland"},{"name":"Mater Misericordiae Hospital; Department of Anaesthesia; Eccles Street Dublin 7 Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C","family":"Henman","sequence":"additional","affiliation":[{"name":"Trinity College Dublin; Centre for the Practice of Pharmacy, School of Pharmacy and Pharmaceutical Sciences; Dublin Ireland Dublin 2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,23]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0001|cit1","first-page":"131","article-title":"Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial","volume":"18","author":"Forssell","year":"2004","journal-title":"Journal of Orofacial Pain"},{"issue":"5","key":"10.1002\/14651858.CD011091.pub2-BIB0002|cit2","first-page":"321","article-title":"Effects of venlafaxine and carbamazepine for painful peripheral diabetic neuropathy: a randomized, double-blind and double-dummy, controlled multi-center trial","volume":"6","author":"Jia","year":"2006","journal-title":"Chinese Journal of Evidence-Based Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011091.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study","volume":"110","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD011091.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","article-title":"Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial","volume":"60","author":"Sindrup","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011091.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/eujp.2001.0266","article-title":"Venlafaxine in neuropathic pain following treatment of breast cancer","volume":"6","author":"Tasmuth","year":"2002","journal-title":"European Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD011091.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpain.2004.09.009","article-title":"The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study","volume":"9","author":"Yucel","year":"2005","journal-title":"European Journal of Pain"},{"issue":"5","key":"10.1002\/14651858.CD011091.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/AJP.0b013e3181cb406e","article-title":"Evaluation of the efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain","volume":"26","author":"Amr","year":"2010","journal-title":"Clinical Journal of Pain"},{"issue":"11","key":"10.1002\/14651858.CD011091.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2337\/diacare.22.11.1909","article-title":"Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules","volume":"22","author":"Davis","year":"1999","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1002\/14651858.CD011091.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00001813-200208000-00013","article-title":"Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine","volume":"13","author":"Durand","year":"2002","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"10.1002\/14651858.CD011091.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/annonc\/mdr045","article-title":"Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial","volume":"23","author":"Durand","year":"2012","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD011091.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jdiacomp.2007.03.010","article-title":"The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus","volume":"22","author":"Kadiroglu","year":"2008","journal-title":"Journal of Diabetes and its Complications"},{"issue":"5","key":"10.1002\/14651858.CD011091.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diacare.23.5.699b","article-title":"Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy","volume":"23","author":"Kiayias","year":"2000","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1002\/14651858.CD011091.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2337\/diacare.23.11.1710","article-title":"Venlafaxine in treatment of painful peripheral diabetic neuropathy","volume":"23","author":"Lithner","year":"2000","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD011091.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0885-3924(00)00151-2","article-title":"Venlafaxine for the treatment of neuropathic pain","volume":"19","author":"Pernia","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD011091.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jpm.2006.9.29","article-title":"Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain","volume":"9","author":"Raskin","year":"2006","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/pme.12456","article-title":"Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of \"easy-to-use\" clinical predictors of early response","volume":"15","author":"Rej","year":"2014","journal-title":"Pain Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpainsymman.2003.06.004","article-title":"Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of post-mastectomy pain syndrome","volume":"27","author":"Reuben","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","article-title":"Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy","volume":"3","author":"Simpson","year":"2001","journal-title":"Journal of Clinical Neuromuscular Disease"},{"issue":"5","key":"10.1002\/14651858.CD011091.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1345\/aph.10206","article-title":"Treatment of neuropathic pain with venlafaxine","volume":"35","author":"Sumpton","year":"2001","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0020|cit20","unstructured":"PaPaS author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"12","key":"10.1002\/14651858.CD011091.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0024-3205(93)90194-8","article-title":"Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes","volume":"52","author":"Bolden-Watson","year":"1993","journal-title":"Life Sciences"},{"issue":"3","key":"10.1002\/14651858.CD011091.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0091270010394852","article-title":"Efficacy of antidepressants as analgesics: a review","volume":"52","author":"Dharmshaktu","year":"2012","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD011091.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1067\/mcp.2001.114873","article-title":"Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans","volume":"69","author":"Enggaard","year":"2001","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2011","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011091.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0029|cit29","first-page":"Art. No: CD1076","article-title":"Imipramine for neuropathic pain in adults","volume":"5","author":"Hearn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0030|cit30","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"18195","DOI":"10.1073\/pnas.0506624102","article-title":"Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans","volume":"102","author":"Iannetti","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD011091.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"10","key":"10.1002\/14651858.CD011091.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"1-3","key":"10.1002\/14651858.CD011091.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0304-3959(96)03223-X","article-title":"Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy","volume":"68","author":"Lang","year":"1996","journal-title":"Pain"},{"issue":"17","key":"10.1002\/14651858.CD011091.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1517\/14656566.2010.507192","article-title":"A review of SSRIs and SNRIs in neuropathic pain","volume":"11","author":"Lee","year":"2010","journal-title":"Expert Opinion in Pharmacotherapy"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0039|cit39","volume-title":"An Evidence-Based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0040|cit40","article-title":"Chronic pain","volume-title":"Health Care Needs Assessment","author":"McQuay","year":"2007"},{"issue":"3","key":"10.1002\/14651858.CD011091.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0042|cit42","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011091.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011091.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011091.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD011091.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011091.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Moore RA Derry S Taylor RS Straube S Phillips CJ The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain Pain Practice 2014 79 94 10.1111\/papr.12050","DOI":"10.1111\/papr.12050"},{"issue":"24","key":"10.1002\/14651858.CD011091.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1016\/0006-2952(86)90769-0","article-title":"Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative","volume":"35","author":"Muth","year":"1986","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/ddr.430230210","article-title":"Biochemical, neurophysiological, and behavioral effects of Wy-45,233 and other identified metabolites of the antidepressant venlafaxine","volume":"23","author":"Muth","year":"1991","journal-title":"Drug Development Research"},{"issue":"1","key":"10.1002\/14651858.CD011091.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0304-3959(92)90144-Z","article-title":"Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies","volume":"49","author":"Onghena","year":"1992","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD011091.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.pain.2011.01.019","article-title":"Chronic pain in the Republic of Ireland - community prevalence, psychosocial profile and predictors of pain-related disability: results from the Prevalence, Impact and Cost of Chronic Pain (PRIME) study, part 1","volume":"152","author":"Raftery","year":"2011","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0059|cit59","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"4","key":"10.1002\/14651858.CD011091.pub2-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005454.pub2","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3940(99)00627-8","article-title":"The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms","volume":"273","author":"Schreiber","year":"1999","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1002\/14651858.CD011091.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3810\/pgm.2010.01.2106","article-title":"Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms","volume":"122","author":"Seo","year":"2010","journal-title":"Postgraduate Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011091.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011091.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011091.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011091.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:33:12Z","timestamp":1704357192000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011091.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,23]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011091.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,23]]}}}